Boxed warning: 3% of patients experienced differentiation syndrome, characterized by symptoms including dyspnea, pleural effusion, pulmonary edema; may be life-threatening or fatal if not treated; Occurred as early as 2 days and up to 75 days following treatment initiation
(194)